Literature DB >> 3757763

Electrocerebral and behavioural analysis of systemic kainic acid-induced epilepsy in the rat.

M Scerrati, M Onofrj, L Pacifici, P Pola, M T Ramacci, G F Rossi.   

Abstract

A systematic study of the epileptic electrocerebral and behavioural effects of intraperitoneal kainic acid (KA) was carried out in 92 adult albino Wistar rats. The doses of KA ranged from 3 to 20 mg/kg. Chronic epidural and stereotaxically implanted cerebral electrodes (hippocampus, amygdala and thalamic reuniens nucleus) were used. All animals were studied for 5-12 after KA injection; in 20 animals the study was extended to 10 days. Sporadic spiking was the early EEG manifestation of epilepsy. Subsequently, ictal discharges were recorded. Both types of epileptic discharges were at first focal and then generalized. In the majority of animals, both types of electrographic events were first recorded from the limbic structures; in 7 to 35% of cases, however (depending on the dose of KA), they first appeared in the neocortex. Two groups of behavioural manifestations were observed: searching, staring spells, wet-dog shaking and gnawing: these could be independent of any recorded EEG epileptic event; and rearing, head nodding, forelimb clonus and tonic-clonic spells: these were always related to EEG epileptic activity, mostly generalized discharges. Spiking was still recorded from various structures 10 days after the KA injection.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3757763

Source DB:  PubMed          Journal:  Drugs Exp Clin Res        ISSN: 0378-6501


  6 in total

1.  Rapid throughput analysis demonstrates that chemicals with distinct seizurogenic mechanisms differentially alter Ca2+ dynamics in networks formed by hippocampal neurons in culture.

Authors:  Zhengyu Cao; Xiaohan Zou; Yanjun Cui; Susan Hulsizer; Pamela J Lein; Heike Wulff; Isaac N Pessah
Journal:  Mol Pharmacol       Date:  2015-01-12       Impact factor: 4.436

Review 2.  Experimental models of status epilepticus and neuronal injury for evaluation of therapeutic interventions.

Authors:  Doodipala Samba Reddy; Ramkumar Kuruba
Journal:  Int J Mol Sci       Date:  2013-09-05       Impact factor: 5.923

3.  NMDA receptor binding in focal epilepsies.

Authors:  C J McGinnity; M J Koepp; A Hammers; D A Riaño Barros; R M Pressler; S Luthra; P A Jones; W Trigg; C Micallef; M R Symms; D J Brooks; J S Duncan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-05-19       Impact factor: 10.154

4.  Glutamate-dependent ectodomain shedding of neuregulin-1 type II precursors in rat forebrain neurons.

Authors:  Yuriko Iwakura; Ran Wang; Naoko Inamura; Kazuaki Araki; Shigeki Higashiyama; Nobuyuki Takei; Hiroyuki Nawa
Journal:  PLoS One       Date:  2017-03-28       Impact factor: 3.240

5.  Autoantibodies to NR2A Peptide of the Glutamate/NMDA Receptor in Patients with Seizure Disorders in Neuropsychiatric Systemic Lupus Erythematosus.

Authors:  Yan Yang; Chao Yuan; Shu-Qun Shen; Xue-Er Wang; Qing-Hua Mei; Wen-Qing Jiang; Qin Huang
Journal:  Mediators Inflamm       Date:  2017-01-05       Impact factor: 4.711

6.  Transgenic overexpression of furin increases epileptic susceptibility.

Authors:  Yi Yang; Miaoqing He; Xin Tian; Yi Guo; Feng Liu; Yun Li; Haiqing Zhang; Xi Lu; Demei Xu; Ruijiao Zhou; Yuanlin Ma; Wei Wang; Guojun Chen; Yida Hu; Xuefeng Wang
Journal:  Cell Death Dis       Date:  2018-10-17       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.